Published in Physician Law Weekly, August 18th, 2004
At constant foreign exchange rates, revenues increased 5%. Revenue growth in all segments benefited from favorable foreign currency translation, particularly with respect to the Euro.
Diluted earnings per share and net income for the quarter were 41 cents and $109 million, respectively. As announced in our July 2, 2004, press release, third quarter results included a pre-tax charge of $100 million relating to the agreement with Retractable Technologies,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly